ESBL-话题@MedSci - 梅斯（MedSci）

[GetTopicListResponse(id=1785774, encodeId=ed761e8577475, content=<a href='/topic/show?id=24fa69e9fd' target=_blank style='color:#2F92EE;'>#ESBL#</a>, objectTitle=带你解读产ESBLs肺炎克雷伯菌, objectType=article, longId=146783, objectId=1b87146e83a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1b87146e83a3, replyNumber=0, likeNumber=68, createdTime=2019-07-21, rootId=0, userName=lvliquan, userId=796422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b87146e83a3, moduleTitle=带你解读产ESBLs肺炎克雷伯菌, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=1b87146e83a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785775, encodeId=99ec1e8577591, content=<a href='/topic/show?id=24fa69e9fd' target=_blank style='color:#2F92EE;'>#ESBL#</a>, objectTitle=J Antimicrob Chemother：产ESBL肠杆菌血流感染，头孢哌酮/舒巴坦PK碳青霉烯类, objectType=article, longId=147530, objectId=132814e53052, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=132814e53052, replyNumber=0, likeNumber=100, createdTime=2019-07-14, rootId=0, userName=lvliquan, userId=796422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=132814e53052, moduleTitle=J Antimicrob Chemother：产ESBL肠杆菌血流感染，头孢哌酮/舒巴坦PK碳青霉烯类, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=132814e53052)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785776, encodeId=04fd1e8577693, content=<a href='/topic/show?id=24fa69e9fd' target=_blank style='color:#2F92EE;'>#ESBL#</a>, objectTitle=经验性治疗我们应该考虑ESBLs?, objectType=article, longId=150424, objectId=13ab15042479, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13ab15042479, replyNumber=0, likeNumber=108, createdTime=2019-06-11, rootId=0, userName=lvliquan, userId=796422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13ab15042479, moduleTitle=经验性治疗我们应该考虑ESBLs?, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=13ab15042479)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785773, encodeId=b4cc1e857735d, content=<a href='/topic/show?id=24fa69e9fd' target=_blank style='color:#2F92EE;'>#ESBL#</a>, objectTitle=Int J Antimicrob Ag：多学科讨论：NICU中产ESBL细菌感染和/或定植的风险因素有哪些？, objectType=article, longId=124793, objectId=fa96124e9321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa96124e9321, replyNumber=0, likeNumber=90, createdTime=2018-01-12, rootId=0, userName=lvliquan, userId=796422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa96124e9321, moduleTitle=Int J Antimicrob Ag：多学科讨论：NICU中产ESBL细菌感染和/或定植的风险因素有哪些？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fa96124e9321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785772, encodeId=63771e8577226, content=<a href='/topic/show?id=24fa69e9fd' target=_blank style='color:#2F92EE;'>#ESBL#</a>, objectTitle=Int J Antimicrob Ag：长期护理病房中的患者有多少发生ESBL-PE定植？, objectType=article, longId=124786, objectId=6bf9124e8659, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6bf9124e8659, replyNumber=0, likeNumber=66, createdTime=2018-07-06, rootId=0, userName=lvliquan, userId=796422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6bf9124e8659, moduleTitle=Int J Antimicrob Ag：长期护理病房中的患者有多少发生ESBL-PE定植？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6bf9124e8659)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785771, encodeId=e10a1e857719e, content=<a href='/topic/show?id=24fa69e9fd' target=_blank style='color:#2F92EE;'>#ESBL#</a>, objectTitle=Clin Infect Dis：ESBL-E引起的血流感染：碳青霉烯类 pk OAD, objectType=article, longId=124776, objectId=3bb5124e76a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3bb5124e76a7, replyNumber=0, likeNumber=66, createdTime=2018-03-27, rootId=0, userName=lvliquan, userId=796422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3bb5124e76a7, moduleTitle=Clin Infect Dis：ESBL-E引起的血流感染：碳青霉烯类 pk OAD, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3bb5124e76a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1785770, encodeId=a3061e85770c7, content=<a href='/topic/show?id=24fa69e9fd' target=_blank style='color:#2F92EE;'>#ESBL#</a>, objectTitle=Int J Antimicrob Agents：ESBL-Ec引发APN：哌拉西林/他唑巴坦是厄他培南治疗的有效替代吗？, objectType=article, longId=98235, objectId=319a982357a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=319a982357a, replyNumber=0, likeNumber=95, createdTime=2018-01-12, rootId=0, userName=lvliquan, userId=796422, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=319a982357a, moduleTitle=Int J Antimicrob Agents：ESBL-Ec引发APN：哌拉西林/他唑巴坦是厄他培南治疗的有效替代吗？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=319a982357a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ESBL

2020-05-29

lvliquan (审核中...)

前往app查看评论内容

#ESBL#

带你解读产ESBLs肺炎克雷伯菌

2019-07-21

lvliquan (审核中...)

前往app查看评论内容

#ESBL#

J Antimicrob Chemother：产ESBL肠杆菌血流感染，头孢哌酮/舒巴坦PK碳青霉烯类

2019-07-14

lvliquan (审核中...)

前往app查看评论内容

#ESBL#

经验性治疗我们应该考虑ESBLs?

2019-06-11

lvliquan (审核中...)

前往app查看评论内容

#ESBL#

Int J Antimicrob Ag：多学科讨论：NICU中产ESBL细菌感染和/或定植的风险因素有哪些？

2018-01-12

lvliquan (审核中...)

前往app查看评论内容

#ESBL#

Int J Antimicrob Ag：长期护理病房中的患者有多少发生ESBL-PE定植？

2018-07-06

lvliquan (审核中...)

前往app查看评论内容

#ESBL#

Clin Infect Dis：ESBL-E引起的血流感染：碳青霉烯类 pk OAD

2018-03-27

lvliquan (审核中...)

前往app查看评论内容

#ESBL#

Int J Antimicrob Agents：ESBL-Ec引发APN：哌拉西林/他唑巴坦是厄他培南治疗的有效替代吗？

2018-01-12

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

#ESBL#

科室

工具

服务